Fibrinogen-tau Aggregates Exacerbate Tau Pathology and Memory Deficits in Alzheimer’s Disease Model Mice

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE. Alzheimer’s disease. Lancet 2021, 397: 1577–1590.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo T, Noble W, Hanger DP. Roles of tau protein in health and disease. Acta Neuropathol 2017, 133: 665–704.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol 2020, 16: 199–212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng H, Sun H, Cai Q, Tai HC. The Enigma of tau protein aggregation: Mechanistic insights and future challenges. Int J Mol Sci 2024, 25: 4969.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laurent C, Buée L, Blum D. Tau and neuroinflammation: What impact for Alzheimer’s disease and tauopathies? Biomed J 2018, 41: 21–33.

Article  PubMed  PubMed Central  Google Scholar 

Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: A cross-sectional study. Lancet Neurol 2016, 15: 934–943.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Huang X, Su Y, Yin G, Wang S, Yu B, et al. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer’s disease. Brain 2022, 145: 4474–4488.

Article  PubMed  PubMed Central  Google Scholar 

Merlini M, Sozmen EG, Subramanian KS, Nana AL, Seeley WW, Akassoglou K. Three-dimensional imaging of fibrinogen and neurovascular alterations in Alzheimer’s disease. Methods Mol Biol 2023, 2561: 87–101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005, 70: 247–299.

Article  CAS  PubMed  Google Scholar 

van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MMB. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 2005, 36: 2637–2641.

Article  PubMed  Google Scholar 

Xu G, Zhang H, Zhang S, Fan X, Liu X. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int J Clin Pract 2008, 62: 1070–1075.

Article  CAS  PubMed  Google Scholar 

Lee JW, Namkoong H, Kim HK, Kim S, Hwang DW, Na HR, et al. Fibrinogen gamma-a chain precursor in CSF: A candidate biomarker for Alzheimer’s disease. BMC Neurol 2007, 7: 14.

Article  PubMed  PubMed Central  Google Scholar 

Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, et al. Plasma biomarkers of brain atrophy in Alzheimer’s disease. PLoS One 2011, 6: e28527.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang H, Lyutvinskiy Y, Herukka SK, Soininen H, Rutishauser D, Zubarev RA. Prognostic polypeptide blood plasma biomarkers of Alzheimer’s disease progression. J Alzheimers Dis 2014, 40: 659–666.

Article  CAS  PubMed  Google Scholar 

Huang S, Wang YJ, Guo J. Biofluid biomarkers of Alzheimer’s disease: Progress, problems, and perspectives. Neurosci Bull 2022, 38: 677–691.

Article  PubMed  PubMed Central  Google Scholar 

Petersen MA, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: Mechanisms, imaging and therapeutics. Nat Rev Neurosci 2018, 19: 283–301.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montagne A, Zhao Z, Zlokovic BV. Alzheimer’s disease: A matter of blood-brain barrier dysfunction? J Exp Med 2017, 214: 3151–3169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin YC, et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun 2015, 3: 8.

Article  PubMed  PubMed Central  Google Scholar 

Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82: 1271–1288.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tennent GA, Brennan SO, Stangou AJ, O’Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood 2007, 109: 1971–1974.

Article  CAS  PubMed  Google Scholar 

Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimers Dement 2016, 12: 719–732.

Article  PubMed  Google Scholar 

LaFerla FM, Oddo S. Alzheimer’s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 2005, 11: 170–176.

Article  CAS  PubMed  Google Scholar 

Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Hemachandra Reddy P. Phosphorylated tau in Alzheimer’s disease and other tauopathies. Int J Mol Sci 2022, 23: 12841.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hainsworth AH, Minett T, Andoh J, Forster G, Bhide I, Barrick TR, et al. Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia. Stroke 2017, 48: 2799–2804.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Z, Liang Y, Zhang X, Xu J, Lin J, Zhang R, et al. Fibrinogen and risk of dementia: A systematic review and meta-analysis. Neurosci Biobehav Rev 2020, 112: 353–360.

Article  CAS  PubMed  Google Scholar 

Cortes-Canteli M, Mattei L, Richards AT, Norris EH, Strickland S. Fibrin deposited in the Alzheimer’s disease brain promotes neuronal degeneration. Neurobiol Aging 2015, 36: 608–617.

Article  CAS  PubMed  Google Scholar 

Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH. Fibrinogen and altered hemostasis in Alzheimer’s disease. J Alzheimers Dis 2012, 32: 599–608.

Article  PubMed  PubMed Central  Google Scholar 

Walsh AC. Anticoagulant therapy for Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1996, 8: 361–362.

Article  CAS  PubMed  Google Scholar 

Walsh AC, Walsh BH, Melaney C. Senile-presenile dementia: Follow-up data on an effective psychotherapy-anticoagulant regimen. J Am Geriatr Soc 1978, 26: 467–470.

Article  CAS  PubMed  Google Scholar 

Barber M, Tait RC, Scott J, Rumley A, Lowe GO, Stott DJ. Dementia in subjects with atrial fibrillation: Hemostatic function and the role of anticoagulation. J Thromb Haemost 2004, 2: 1873–1878.

Article  CAS  PubMed 

Comments (0)

No login
gif